| 1 |
Bostanshirin N, Hajikhani B, Vaezi AA, Kermanian F, Sameni F, Yaslianifard S, Goudarzi M, Dadashi M. Association between colorectal cancer and expression levels of miR-21, miR-17-5P, miR-155 genes and the presence of Fusobacterium nucleatum in biopsy samples obtained from Iranian patients. Infect Agent Cancer 2023;18:14. [PMID: 36859379 DOI: 10.1186/s13027-023-00494-y] [Reference Citation Analysis]
|
| 2 |
Bukavina L, Ginwala R, Sindhani M, Prunty M, Geynisman D, Pooja G, Valentine H, Calaway A, Brown JR, Correa A, Mishra K, Pominville R, Plimack E, Kutikov A, Ghannoum M, ElShaer M, Retuerto M, Uzzo R, Ponsky L, Abbosh PH. Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation. bioRxiv 2023:2023. [PMID: 36747848 DOI: 10.1101/2023.01.21.525021] [Reference Citation Analysis]
|
| 3 |
Ali AliMohammadi, Nahid Chezani-sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati, Ehsanollah Ghaznavi-Rad. The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19. Vacunas (English Edition) 2023;24. [ DOI: 10.1016/j.vacune.2023.02.002] [Reference Citation Analysis]
|
| 4 |
AliMohammadi A, Chezani-Sharahi N, Hezaveh ZA, Abbasi E, Shariati A, Ghaznavi-Rad E. The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19. Vacunas 2023;24:13-8. [PMID: 36341004 DOI: 10.1016/j.vacun.2022.10.004] [Reference Citation Analysis]
|
| 5 |
Mbatha SZ, Mkhize-kwitshana ZL, Mulaudzi TV, Hull R, Dlamini Z. Artificial Intelligence Application to Microbiomics Data for Improved Clinical Decision Making in Precision Oncology. Artificial Intelligence and Precision Oncology 2023. [DOI: 10.1007/978-3-031-21506-3_8] [Reference Citation Analysis]
|
| 6 |
John Kenneth M, Tsai HC, Fang CY, Hussain B, Chiu YC, Hsu BM. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer. J Adv Res 2022:S2090-1232(22)00295-8. [PMID: 36596411 DOI: 10.1016/j.jare.2022.12.015] [Reference Citation Analysis]
|
| 7 |
Hino A, Fukushima K, Kusakabe S, Ueda T, Sudo T, Fujita J, Motooka D, Takeda AK, Shinozaki NO, Watanabe S, Yokota T, Shibayama H, Nakamura S, Hosen N. Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation. Br J Haematol 2022. [PMID: 36468273 DOI: 10.1111/bjh.18574] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Lo CH, Wu DC, Jao SW, Wu CC, Lin CY, Chuang CH, Lin YB, Chen CH, Chen YT, Chen JH, Hsiao KH, Chen YJ, Chen YT, Wang JY, Li LH. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas. J Biomed Sci 2022;29:88. [PMID: 36303164 DOI: 10.1186/s12929-022-00869-0] [Reference Citation Analysis]
|
| 9 |
Aziz S, Rasheed F, Akhter TS, Zahra R, König S. Microbial Proteins in Stomach Biopsies Associated with Gastritis, Ulcer, and Gastric Cancer. Molecules 2022;27:5410. [DOI: 10.3390/molecules27175410] [Reference Citation Analysis]
|
| 10 |
Taati Moghadam M, Amirmozafari N, Mojtahedi A, Bakhshayesh B, Shariati A, Masjedian Jazi F. Association of perturbation of oral bacterial with incident of Alzheimer's disease: A pilot study. J Clin Lab Anal 2022;36:e24483. [PMID: 35689551 DOI: 10.1002/jcla.24483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 11 |
Chegini Z, Shariati A, Asghari A, Rajaeih S, Ghorbani M, Jalessi M, Mirshekar M, Razavi S. Molecular analysis of dominant paranasal sinus bacteria in patients with and without chronic rhinosinusitis. Arch Microbiol 2022;204:327. [PMID: 35575834 DOI: 10.1007/s00203-022-02914-w] [Reference Citation Analysis]
|
| 12 |
Scott N, Whittle E, Jeraldo P, Chia N. A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer. Neoplasia 2022;29:100797. [PMID: 35461079 DOI: 10.1016/j.neo.2022.100797] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 13 |
Tang JW, Liu X, Ye W, Li ZR, Qian PY. Biosynthesis and bioactivities of microbial genotoxin colibactins. Nat Prod Rep 2022. [PMID: 35288725 DOI: 10.1039/d1np00050k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Li R, Shen J, Xu Y. Fusobacterium nucleatum and Colorectal Cancer. IDR 2022;Volume 15:1115-20. [DOI: 10.2147/idr.s357922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Khodaverdi N, Zeighami H, Jalilvand A, Haghi F, Hesami N. High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients. BMC Cancer 2021;21. [DOI: 10.1186/s12885-021-09110-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 16 |
Liu K, Yang X, Zeng M, Yuan Y, Sun J, He P, Sun J, Xie Q, Chang X, Zhang S, Chen X, Cai L, Xie Y, Jiao X. The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer. Dis Markers 2021;2021:1171239. [PMID: 34853619 DOI: 10.1155/2021/1171239] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Choi S, Chung J, Cho ML, Park D, Choi SS. Analysis of changes in microbiome compositions related to the prognosis of colorectal cancer patients based on tissue-derived 16S rRNA sequences. J Transl Med 2021;19:485. [PMID: 34844611 DOI: 10.1186/s12967-021-03154-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 18 |
Johnstone KLF, Toomey S, Madden S, O'Neill BDP, Hennessy BT. Fusobacterium nucleatum: caution with interpreting historical patient sample cohort. J Pathol Transl Med 2021;55:415-8. [PMID: 34555886 DOI: 10.4132/jptm.2021.08.27] [Reference Citation Analysis]
|
